Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Vogelzang

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Metronomic chemotherapy: teaching old drugs new tricks?Nicholas Vogelzang
Clinical Genitourinary Cancer|January 7, 2011
Advanced prostate cancer 2010: what a year!Oliver Sartor, Nicholas Vogelzang
Reviews in Urology|October 6, 2006
Monitoring response, prediction methodology, staging, and imaging in prostate cancerDavid Pomerantz, Nicholas Vogelzang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Newer issues in mesothelioma chemotherapyNicholas Vogelzang, Harvey I Pass
Integrative Cancer Therapies|March 24, 2004
Integrative tumor board: metastatic renal cell carcinoma: medical oncologySupriya K Gupta, Nicholas Vogelzang
Plos One|May 10, 2013
Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy eraSumanta K Pal, Rebecca A Nelson, Nicholas Vogelzang
Clinical Genitourinary Cancer|May 8, 2013
A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysisRebecca A Nelson, Nicholas Vogelzang, Sumanta K Pal
Current Problems in Cancer|June 16, 2004
Malignant pleural mesotheliomaHarvey I Pass, Nicholas Vogelzang, Steven Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the DetailsMaha Hussain, Catherine Tangen, Celestia Higano, et al.
Clinical Genitourinary Cancer|January 11, 2020
Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate CancerJulianna Higa, Kirk Wilenius, Shannon Savino, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Metronomic chemotherapy: teaching old drugs new tricks?Nicholas Vogelzang
Clinical Genitourinary Cancer|January 7, 2011
Advanced prostate cancer 2010: what a year!Oliver Sartor, Nicholas Vogelzang
Reviews in Urology|October 6, 2006
Monitoring response, prediction methodology, staging, and imaging in prostate cancerDavid Pomerantz, Nicholas Vogelzang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Newer issues in mesothelioma chemotherapyNicholas Vogelzang, Harvey I Pass
Integrative Cancer Therapies|March 24, 2004
Integrative tumor board: metastatic renal cell carcinoma: medical oncologySupriya K Gupta, Nicholas Vogelzang
Plos One|May 10, 2013
Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy eraSumanta K Pal, Rebecca A Nelson, Nicholas Vogelzang
Clinical Genitourinary Cancer|May 8, 2013
A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysisRebecca A Nelson, Nicholas Vogelzang, Sumanta K Pal
Current Problems in Cancer|June 16, 2004
Malignant pleural mesotheliomaHarvey I Pass, Nicholas Vogelzang, Steven Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the DetailsMaha Hussain, Catherine Tangen, Celestia Higano, et al.
Clinical Genitourinary Cancer|January 11, 2020
Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate CancerJulianna Higa, Kirk Wilenius, Shannon Savino, et al.
Pageof 4